Chlortetracycline is tetracycline with a 7-chloro substitution. Chlortetracycline is considered the drug of choice for the treatment of ocular infections combined with erythromycin and in donovanosis infection. Chlortetracycline is also indicated in combination with other tetracyclines for the treatment of gonorrhea to eradicate possible coexistent non-gonococcal urethritis and for treatment of Chlamydia genitourinary infections. Chlortetracycline has shown therapeutic efficacy in the treatment of recurrent mouth ulcers, dry sockets from tooth extraction and fluid buildup around a testicle.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), and to obtain the following information:
To order an OEL monograph for this compound, just click the ADD TO CART button.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’s OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.